GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Cardiac Disease
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
Trials & Approvals Blood Cancer
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Trials & Approvals CAR T-cell Therapy
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
Trials & Approvals Migraine
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Trials & Approvals Obesity
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Trials & Approvals Alzheimer's Disease
Cortexyme’s Shares Implode after Alzheimer’s Disease Drug Flunks Trial
2021-10-29
Policy Rare Disease
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Gene Therapy
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
1 … 26 27 28 29 30 … 53
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top